Liu Baike, Qin Zijian, Cai Zhaolun, Liu Zheran, Chen Yun-Lin, Yin Xiaonan, Yin Yuan, Peng Xingchen, Zhang Bo
Gastric Cancer Center, Department of General Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.
State Key Laboratory of Biotherapy, Sichuan University, Chengdu 610041, China.
Biomedicines. 2023 Sep 15;11(9):2543. doi: 10.3390/biomedicines11092543.
Observational studies suggested that inflammatory bowel disease (IBD) (i.e., Crohn's disease [CD] and ulcerative colitis [UC]) is associated with an increased risk of atherosclerotic cardiovascular disease (ASCVD), including coronary artery disease (CAD) and ischemic stroke. However, it is still unclear whether the observed associations causally exist. Thus, we aim to examine the potential effect of IBD, CD, and UC on the risk of CAD and ischemic stroke, using a two-sample Mendelian randomization (MR) study.
Genetic instruments for IBD, CD, and UC were retrieved from the latest published genome-wide association studies (GWASs) of European ancestry. GWAS summary data for instrument-outcome associations were gathered from four independent resources: CARDIoGRAMplusC4D Consortium, MEGASTROKE consortium, FinnGen, and UK Biobank. The inverse variance weighted (IVW) method and multiple pleiotropy-robust approaches were conducted and, subsequently, combined in a fixed-effect meta-analysis. Moreover, multivariable MR (MVMR) analysis was conducted to adjust for potential influencing instrumental variables.
The IVW method revealed no causal effect of IBD on the risk of CAD (overall IBD on CAD: OR 1.003, 95%CI 0.982 to 1.025; CD on CAD: OR 0.997, 95%CI 0.978 to 1.016; UC on CAD: OR 0.986, 95%CI 0.963 to 1.010) or the risk of ischemic stroke (overall IBD on ischemic stroke: OR 0.994, 95%CI 0.970 to 1.018; CD on ischemic stroke: OR 0.996, 95%CI 0.979 to 1.014; UC on ischemic stroke: OR 0.999, 95%CI 0.978 to 1.020). The results of the meta-analysis and MVMR remained consistent.
Our MR analysis does not support a causal effect of IBD on CAD and ischemic stroke, and previous results from observational studies might be biased through uncontrolled confoundings (such as IBD-specific medications and detection bias, etc.) that warrant further research.
观察性研究表明,炎症性肠病(IBD)(即克罗恩病[CD]和溃疡性结肠炎[UC])与动脉粥样硬化性心血管疾病(ASCVD)风险增加相关,包括冠状动脉疾病(CAD)和缺血性中风。然而,所观察到的关联是否存在因果关系仍不清楚。因此,我们旨在通过双样本孟德尔随机化(MR)研究,探讨IBD、CD和UC对CAD和缺血性中风风险的潜在影响。
从最新发表的欧洲血统全基因组关联研究(GWAS)中检索IBD、CD和UC的遗传工具。工具-结局关联的GWAS汇总数据来自四个独立资源:CARDIoGRAMplusC4D联盟、MEGASTROKE联盟、芬兰基因研究和英国生物银行。采用逆方差加权(IVW)方法和多种多效性稳健方法,随后进行固定效应荟萃分析。此外,进行多变量MR(MVMR)分析以调整潜在影响工具变量。
IVW方法显示IBD对CAD风险无因果效应(IBD总体对CAD:比值比[OR]1.003,95%置信区间[CI]0.982至1.025;CD对CAD:OR0.997,95%CI0.978至1.016;UC对CAD:OR0.986,95%CI0.963至1.010)或缺血性中风风险(IBD总体对缺血性中风:OR0.994,95%CI0.970至1.018;CD对缺血性中风:OR0.996,95%CI0.979至1.014;UC对缺血性中风:OR0.999,95%CI0.978至1.020)。荟萃分析和MVMR的结果保持一致。
我们的MR分析不支持IBD对CAD和缺血性中风有因果效应,观察性研究先前的结果可能因未控制的混杂因素(如IBD特异性药物和检测偏倚等)而存在偏差,这值得进一步研究。